[
  {
    "ts": "2025-09-10T11:11:37+00:00",
    "headline": "A Look at Kenvue's (KVUE) Valuation as Tylenol–Autism Reports Spark Investor Uncertainty",
    "summary": "If you have been watching Kenvue (KVUE) lately, there is a good chance the news has caught your attention. A series of high-profile reports suggest that federal health officials, including Health Secretary RFK Jr., may soon associate the use of Tylenol during pregnancy with autism. This potential warning is stirring investor anxiety, not just because Tylenol is a flagship product but also due to the ripple effect such health concerns can have on market sentiment. The fallout has been swift,...",
    "url": "https://finance.yahoo.com/news/look-kenvues-kvue-valuation-tylenol-111137847.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "bbe58c8b-6dbf-356f-9a0e-63174e5e7dd0",
      "content": {
        "id": "bbe58c8b-6dbf-356f-9a0e-63174e5e7dd0",
        "contentType": "STORY",
        "title": "A Look at Kenvue's (KVUE) Valuation as Tylenol–Autism Reports Spark Investor Uncertainty",
        "description": "",
        "summary": "If you have been watching Kenvue (KVUE) lately, there is a good chance the news has caught your attention. A series of high-profile reports suggest that federal health officials, including Health Secretary RFK Jr., may soon associate the use of Tylenol during pregnancy with autism. This potential warning is stirring investor anxiety, not just because Tylenol is a flagship product but also due to the ripple effect such health concerns can have on market sentiment. The fallout has been swift,...",
        "pubDate": "2025-09-10T11:11:37Z",
        "displayTime": "2025-09-10T11:11:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W2Y4xgPz6k2sJssKwLaiuQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XxQ2W.u4ql9pr6kIHenw7g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d690536de0c7b23c26cf14ed9066767e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/look-kenvues-kvue-valuation-tylenol-111137847.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/look-kenvues-kvue-valuation-tylenol-111137847.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]